Back to Results
Elisabeth (Elise) A. Merchant, MD
Department + Services
Medicine, Geographic Medicine and Infectious Diseases
Clinical Focus Areas
General infectious diseases, care and treatment of HIV/AIDS, pre-exposure prophylaxis (PrEP) for HIV, post-exposure prophylaxis, sexually transmitted infection testing and treatment, treatment and prevention of infections in LQTBQIA+ people, treatment and prevention of infections in people who inject drugs
Research Focus Areas
Medical education, PrEP
Seeing Patients In
Tufts Medical Center
Biewend Building, 3rd Floor
800 Washington Street
Boston, MA 02111
Phone #: 617-636-7010
Fax #: 617-636-7100
Alpha Omega Alpha Honors Society
Merchant EA, Flint K, Barouch DH, Blair BM. Co-infection with Coronavirus Disease 2019, previosuly undiagnosed Human Immunodeficiency Virus, Pneumocystis jirovecii pneumonia and Cytomegalovirus pneumonitis, with possible Immune Reconstitution Inflammatory Syndrome. IDCases. 2021 May 7;24e01153. Epub ahead of print. PMID:22977081; PMCID: PMC8103711.
Merchant E, Burke D, Shaw L, Tookes H, Patil D, Barocas J, Wurcel A. Hospitalization Outcomes of People Who Use Drugs: One Size Does Not Fit All. Journal of Substance Abuse Treatment. 2020 May; 112:23-28. doi: 10.1016/j.jsat.2020.01.010. Epub 2020 Jan 22.
Wurcel AG, Merchant EA, Clark RP, Stone DR. Emerging and Underrecognized Complications of Illicit Drug Use. Clinical Infectious Diseases. 2015 Dec 15;61(12):1840-9. PMID 26270683.
Jindal HK, Merchant E, Balschi JA, Zhangand Y, Koren G. Proteomic analyses of transgenic LQT1 and LQT2 rabbit hearts elucidate an increase in expression and activity of energy producing enzymes. Journal of Proteomics. 2012 Sep 18;75(17):5254-65. PMID: 22796357.
HIV/STD/STI testing and counseling; Provision of PrEP and/or PEP for patients at risk for HIVHIV care and services; LGBTQ-focused alcohol and substance use treatment; Comprehensive, multidisciplinary clinical care program for transgender adults